International Journal of Infection

Published by: Kowsar

Antimicrobial Resistance Patterns of Vibrio cholera Strains Isolated From Afghan and Iranian Patients in Iran

Seyed Mehdi Tabatabaei 1 , * and Alireza Salimi Khorashad 1
Authors Information
1 Infectious Diseases and Tropical Medicine Research Center, Zahedan University of Medical Sciences, Zahedan, IR Iran
Article information
  • International Journal of Infection: January 01, 2015, 2 (1); e22822
  • Published Online: January 20, 2015
  • Article Type: Research Article
  • Received: August 16, 2014
  • Accepted: August 16, 2014
  • DOI: 10.17795/iji-22822

To Cite: Tabatabaei S M, Salimi Khorashad A. Antimicrobial Resistance Patterns of Vibrio cholera Strains Isolated From Afghan and Iranian Patients in Iran, Int J Infect. 2015 ; 2(1):e22822. doi: 10.17795/iji-22822.

Copyright © 2015, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. World Health Organization . Cholera 2014;
  • 2. Piarroux R, Faucher B. Cholera epidemics in 2010: respective roles of environment, strain changes, and human-driven dissemination. Clin Microbiol Infect. 2012; 18(3): 231-8[DOI][PubMed]
  • 3. Sharifi Mood B, Metanat M. Diagnosis, Clinical Management, Prevention, and Control of Cholera; A Review Study. Int J Infect. 2014; 1(1)
  • 4. Finkelstein RA. Medical Microbiology. 1996;
  • 5. Mandal S, Mandal MD, Pal NK. Cholera: a great global concern. Asian Pac J Trop Med. 2011; 4(7): 573-80[DOI][PubMed]
  • 6. Cash RA, Music SI, Libonati JP, Snyder MJ, Wenzel RP, Hornick RB. Response of man to infection with Vibrio cholerae. I. Clinical, serologic, and bacteriologic responses to a known inoculum. J Infect Dis. 1974; 129(1): 45-52[PubMed]
  • 7. Pierce NF, Banwell JG, Mitra RC, Caranasos GJ, Keimowitz RI, Thomas J, et al. Controlled comparison of tetracycline and furazolidone in cholera. Br Med J. 1968; 3(5613): 277-80[PubMed]
  • 8. Narang P, Mendiratta DK, Deotale VS, Narang R. Changing patterns of Vibrio cholerae in sevagram between 1990 and 2005. Indian J Med Microbiol. 2008; 26(1): 40-4[PubMed]
  • 9. Kitaoka M, Miyata ST, Unterweger D, Pukatzki S. Antibiotic resistance mechanisms of Vibrio cholerae. J Med Microbiol. 2011; 60: 397-407[DOI][PubMed]
  • 10. Mahmood A. Emergence of nalidixic acid resistant Vibrio cholerae O-1 in Karachi. J Pak Med Assoc. 1999; 49(11): 286[PubMed]
  • 11. Sjolund-Karlsson M, Reimer A, Folster JP, Walker M, Dahourou GA, Batra DG, et al. Drug-resistance mechanisms in Vibrio cholerae O1 outbreak strain, Haiti, 2010. Emerg Infect Dis. 2011; 17(11): 2151-4[DOI][PubMed]
  • 12. Okeke IN, Lamikanra A, Edelman R. Socioeconomic and behavioral factors leading to acquired bacterial resistance to antibiotics in developing countries. Emerg Infect Dis. 1999; 5(1): 18-27[DOI][PubMed]
  • 13. Cohen ML. Epidemiological factors influencing the emergence of antimicrobial resistance. Ciba Found Symp. 1997; 207: 223-31[PubMed]
  • 14. Das S, Choudhry S, Saha R, Ramachandran VG, Kaur K, Sarkar BL. Emergence of multiple drug resistance Vibrio cholerae O1 in East Delhi. J Infect Dev Ctries. 2011; 5(4): 294-8[PubMed]
  • 15. Sargolzaie N, Kiani M. Cholera Outbreaks Evaluation in Sistan and Baluchestan Province of Iran. Int J Infect . 2014; 1(1)
  • 16. Sheikh A, Khan A, Malik T, Fisher-Hoch SP. Cholera in a developing megacity; Karachi, Pakistan. Epidemiol Infect. 1997; 119(3): 287-92[PubMed]
  • 17. Jabeen K, Zafar A, Hasan R. Increased isolation of Vibrio cholerae O1 serotype Inaba over serotype Ogawa in Pakistan. East Mediterr Health J. 2008; 14(3): 564-70[PubMed]
  • 18. Salimi Khorashad A, Tabatabaee SM, Amirabadi A, Roudbar Mohamadi S. Vibrio cholerae and Changing of Microbial Resistance Patterns in Sistan and Balouchestan Province. Zahedan J Res Med Sci. 2012; 14(8): 63-6
  • 19. Hudzicki J. Kirby-Bauer Disk Diffusion Susceptibility Test Protocol: American Society for Microbiology. 2013;
  • 20. Clinical and Laboratory Standards Institute . Performance Standards for Antimicrobial Susceptibility Testing, Seventeenth Informational Supplement 2010;
  • 21. Bopp CA, Ries AA, Wells JG. Laboratory methods for the diagnosis of epidemic dysentery and cholera 1999;
  • 22. Keramat F, Hashemi SH, Mamani M, Ranjbar M, Erfan H. Survey of antibiogram tests in cholera patients in the 2005 epidemic in Hamadan, Islamic Republic of Iran. East Mediterr Health J. 2008; 14(4): 768-75[PubMed]
  • 23. Adabi M, Bakhshi B, Goudarzi H, Zahraei SM, Pourshafie MR. Distribution of class I integron and sulfamethoxazole trimethoprim constin in Vibrio cholerae isolated from patients in Iran. Microb Drug Resist. 2009; 15(3): 179-84[DOI][PubMed]
  • 24. Nizami SQ, Farooqui BJ. Cholera in children in Karachi from 1990 through 1995: a study of cases admitted to a tertiary care hospital. J Pak Med Assoc. 1998; 48(6): 171-3[PubMed]
  • 25. Shah MA, Mutreja A, Thomson N, Baker S, Parkhill J, Dougan G, et al. Genomic epidemiology of Vibrio cholerae O1 associated with floods, Pakistan, 2010. Emerg Infect Dis. 2014; 20(1): 13-20[DOI][PubMed]
  • 26. Jabeen K, Hasan R. Re-emergence of Vibrio cholerae O139 in Pakistan: report from a tertiary care hospital. J Pak Med Assoc. 2003; 53(8): 335-8[PubMed]
  • 27. Urassa WK, Mhando YB, Mhalu FS, Mjonga SJ. Antimicrobial susceptibility pattern of Vibrio cholerae O1 strains during two cholera outbreaks in Dar es Salaam, Tanzania. East Afr Med J. 2000; 77(7): 350-3[PubMed]
  • 28. Abera B, Bezabih B, Dessie A. Antimicrobial suceptibility of V. cholerae in north west, Ethiopia. Ethiop Med J. 2010; 48(1): 23-8[PubMed]
  • 29. Manga NM, Ndour CT, Diop SA, Dia NM, Ka-Sall R, Diop BM, et al. [Cholera in Senegal from 2004 to 2006: lessons learned from successive outbreaks]. Med Trop (Mars). 2008; 68(6): 589-92[PubMed]
  • 30. Jain M, Kushwah KS, Kumar P, Goel AK. Molecular Characterization of Vibrio cholerae O1 Reveals Continuous Evolution of Its New Variants in India. Indian J Microbiol. 2013; 53(2): 137-41[DOI][PubMed]
  • 31. Das S, Saha R, Kaur IR. Trend of antibiotic resistance of Vibrio cholerae strains from East Delhi. Indian J Med Res. 2008; 127(5): 478-82[PubMed]
  • 32. Chandrasekhar MR, Krishna BV, Patil AB. Changing characteristics of Vibrio cholerae: emergence of multidrug resistance and non-O1, non-O139 serogroups. Southeast Asian J Trop Med Public Health. 2008; 39(6): 1092-7[PubMed]
  • 33. Supawat K, Huttayananont S, Sawanpanyalert P, Aswapokee N, Mootsikapun P. Antimicrobial resistance surveillance of Vibrio cholerae in Thailand from 2000 to 2004. J Med Assoc Thai. 2009; 92 Suppl 4-6[PubMed]
  • 34. Noeske J, Guevart E, Kuaban C, Solle J, Fonkoua MC, Mouangue A, et al. Routine use of antimicrobial drugs during the 2004 cholera epidemic in Douala, Cameroon. East Afr Med J. 2006; 83(11): 596-601[PubMed]
  • 35. Sack DA, Lyke C, McLaughlin C, Suwanvanichkij V. Antimicrobial resistance in shigellosis, cholera, and campylobacteriosis. 2001;
  • 36. Klontz EH, Das SK, Ahmed D, Ahmed S, Chisti MJ, Malek MA, et al. Long-term comparison of antibiotic resistance in Vibrio cholerae O1 and Shigella species between urban and rural Bangladesh. Clin Infect Dis. 2014; 58(9)-6[DOI][PubMed]
  • 37. Garg P, Chakraborty S, Basu I, Datta S, Rajendran K, Bhattacharya T, et al. Expanding multiple antibiotic resistance among clinical strains of Vibrio cholerae isolated from 1992-7 in Calcutta, India. Epidemiol Infect. 2000; 124(3): 393-9[PubMed]
  • 38. Sack RB, Rahman M, Yunus M, Khan EH. Antimicrobial resistance in organisms causing diarrheal disease. Clin Infect Dis. 1997; 24 Suppl 1-5[PubMed]
  • 39. Ilic K, Jakovljevic E, Skodric-Trifunovic V. Social-economic factors and irrational antibiotic use as reasons for antibiotic resistance of bacteria causing common childhood infections in primary healthcare. Eur J Pediatr. 2012; 171(5): 767-77[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments